Cresilon

Cresilon Cresilon, Inc. is a medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments.

Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com.

--
DISCLAIMER: The products and the claims made about specific products on or through this site have not been evaluated by the United States Food and Drug

Administration (FDA) and are not approved to diagnose, treat, cure, or prevent disease. This notice will be updated upon FDA approval.

Come by booth 545 at NTOA 2026 to learn more about TRAUMAGEL. TRAUMAGEL has been tested in and recommended by members of...
08/28/2026

Come by booth 545 at NTOA 2026 to learn more about TRAUMAGEL. TRAUMAGEL has been tested in and recommended by members of the National Tactical Officers Association receiving a gold logo standard.

traumagel.com

Proud to see South Kingstown EMS training with TRAUMAGEL® to help control external moderate to severe bleeding when seco...
08/26/2026

Proud to see South Kingstown EMS training with TRAUMAGEL® to help control external moderate to severe bleeding when seconds matters.

traumagel.com

08/05/2026

It was great to be at MHSRS 2026, connecting with military health professionals and sharing the latest on TRAUMAGEL. Thank you to everyone who stopped by our booth and joined the conversation.

traumagel.com

Join us at MHSRS on August 4 from 3:30–5:30 PM for a poster presentation featuring a remote care case report on TRAUMAGE...
08/04/2026

Join us at MHSRS on August 4 from 3:30–5:30 PM for a poster presentation featuring a remote care case report on TRAUMAGEL® in an austere environment.

traumagel.com

Stop by booth 518 at MHSRS to learn more about TRAUMAGEL®traumagel.com
08/03/2026

Stop by booth 518 at MHSRS to learn more about TRAUMAGEL®

traumagel.com

A new peer-reviewed case series examines the use of TRAUMAGEL® for hemorrhage control and tourniquet removal in traumati...
07/07/2026

A new peer-reviewed case series examines the use of TRAUMAGEL® for hemorrhage control and tourniquet removal in traumatic extremity injuries. Across three clinical cases, TRAUMAGEL helped achieve sustained hemorrhage control and enabled tourniquet removal without rebleeding.

The study was authored by trauma and emergency medicine clinicians from Louisiana State University Health Sciences Center and East Baton Rouge Parish EMS.

Read the full study highlights: https://cresilon.com/2026/07/07/traumagel-study-highlights-sustained-hemorrhage-control-and-tourniquet-removal-without-rebleeding/

Clinical cases demonstrate successful use of TRAUMAGEL during tourniquet conversion in prolonged field care, including in gunshot wounds, industrial trauma and sharp-force injuries NEW YORK (July 7, 2026) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostati...

07/04/2026

Celebrating America’s 250th. Happy Independence Day.

06/09/2026

See how TRAUMAGEL® stands out to these EMTs.

“What stood out most to me was how quick it was to learn how to use, and how quickly it completely stopped bleeding. It worked super fast, a lot faster than anything else I’ve ever used.” - Zach Papoutsis, Firefighter/EMT, Cobb County Fire & Emergency Services

Learn more at traumagel.com

06/02/2026

“I am alive, and it saved me from losing my hand.” - Casey Bolin, Patient

Real-world feedback on TRAUMAGEL® from the field.

Learn more at traumagel.com

This Memorial Day, we remember and honor the heroes who served our nation.
05/25/2026

This Memorial Day, we remember and honor the heroes who served our nation.

Address

122 18th Street
Brooklyn, NY
11215

Alerts

Be the first to know and let us send you an email when Cresilon posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cresilon:

Shortcuts

Share